Literature DB >> 19278315

In utero meconium passage in fetuses and newborns with myelomeningocele.

Enrico Danzer1, Linda M Ernst, Natalie E Rintoul, Mark P Johnson, N Scott Adzick, Alan W Flake.   

Abstract

OBJECT: The authors retrospectively investigated whether midgestational fetal myelomeningocele (fMMC) repair alters intrauterine meconium exposure.
METHODS: Prior to the National Institutes of Health Management of Myelomeningocele Study, 54 fetuses underwent fMMC repair at the authors' institution. Forty-six fMMC sacs were available for pathological examination and 53 MMC sacs from postnatally repaired MMCs (pMMCs) were available for comparison. The presence and distribution of meconium were blindly evaluated using a grading system defined as follows: absent (no meconium present), mild (<10 meconium-positive histiocytes [MPHs]/hpf), moderate (10-25 MPHs/hpf), and severe (>25 MPHs/hpf). Hall's bile stain was used to confirm meconium and Prussian blue and Fontana Masson stains to exclude hemosiderin and melanin, respectively.
RESULTS: Compared to pMMCs (79%), meconium histiocytosis was less prevalent in fMMC sacs (57%; p=0.017). Meconium staining was completely absent in 43% of the fMMC sacs. Mild meconium histiocytosis was found in 35% fMMC and 61% pMMC sacs (p=0.035). There was no statistical difference between groups with moderate and severe meconium histiocytosis.
CONCLUSIONS: Meconium passage in MMCs can occur early in fetal life. Fetal MMC repair may reduce the duration of meconium exposure, thereby potentially limiting the toxic injury to the vulnerable neural elements.

Entities:  

Mesh:

Year:  2009        PMID: 19278315     DOI: 10.3171/2008.10.PEDS08199

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  4 in total

1.  Children with tethered cord syndrome of different etiology benefit from microsurgery-a single institution experience.

Authors:  Pantelis Stavrinou; Mathias Kunz; Markus Lehner; Alfred Heger; Wolfgang Müller-Felber; Joerg-Christian Tonn; Aurelia Peraud
Journal:  Childs Nerv Syst       Date:  2011-01-06       Impact factor: 1.475

2.  Therapeutic potential of in utero mesenchymal stem cell (MSCs) transplantation in rat foetuses with spina bifida aperta.

Authors:  Hui Li; Fei Gao; Lili Ma; Junhong Jiang; Jianing Miao; Mingyu Jiang; Yang Fan; Lili Wang; Di Wu; Bo Liu; Weilin Wang; Vincent Chi Hang Lui; Zhengwei Yuan
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

3.  Correlation between spina bifida manifesta in fetal rats and c-Jun N-terminal kinase signaling.

Authors:  Yinghuan Ma; Yongxin Bao; Chenghao Li; Fubin Jiao; Hongjie Xin; Zhengwei Yuan
Journal:  Neural Regen Res       Date:  2012-11-15       Impact factor: 5.135

4.  Application potential of bone marrow mesenchymal stem cell (BMSCs) based tissue-engineering for spinal cord defect repair in rat fetuses with spina bifida aperta.

Authors:  Xiaoshuai Li; Zhengwei Yuan; Xiaowei Wei; Hui Li; Guifeng Zhao; Jiaoning Miao; Di Wu; Bo Liu; Songying Cao; Dong An; Wei Ma; Henan Zhang; Weilin Wang; Qiushi Wang; Hui Gu
Journal:  J Mater Sci Mater Med       Date:  2016-02-19       Impact factor: 3.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.